Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Denmark.
Am J Clin Nutr. 2012 Feb;95(2):283-9. doi: 10.3945/ajcn.111.022533. Epub 2011 Dec 28.
The consumption of sucrose-sweetened soft drinks (SSSDs) has been associated with obesity, the metabolic syndrome, and cardiovascular disorders in observational and short-term intervention studies. Too few long-term intervention studies in humans have examined the effects of soft drinks.
We compared the effects of SSSDs with those of isocaloric milk and a noncaloric soft drink on changes in total fat mass and ectopic fat deposition (in liver and muscle tissue).
Overweight subjects (n = 47) were randomly assigned to 4 different test drinks (1 L/d for 6 mo): SSSD (regular cola), isocaloric semiskim milk, aspartame-sweetened diet cola, and water. The amount of intrahepatic fat and intramyocellular fat was measured with (1)H-magnetic resonance spectroscopy. Other endpoints were fat mass, fat distribution (dual-energy X-ray absorptiometry and magnetic resonance imaging), and metabolic risk factors.
The relative changes between baseline and the end of 6-mo intervention were significantly higher in the regular cola group than in the 3 other groups for liver fat (132-143%, sex-adjusted mean; P < 0.01), skeletal muscle fat (117-221%; P < 0.05), visceral fat (24-31%; P < 0.05), blood triglycerides (32%; P < 0.01), and total cholesterol (11%; P < 0.01). Total fat mass was not significantly different between the 4 beverage groups. Milk and diet cola reduced systolic blood pressure by 10-15% compared with regular cola (P < 0.05). Otherwise, diet cola had effects similar to those of water.
Daily intake of SSSDs for 6 mo increases ectopic fat accumulation and lipids compared with milk, diet cola, and water. Thus, daily intake of SSSDs is likely to enhance the risk of cardiovascular and metabolic diseases. This trial is registered at clinicaltrials.gov as NCT00777647.
在观察性和短期干预研究中,蔗糖甜味软饮料(SSSD)的消费与肥胖、代谢综合征和心血管疾病有关。在人类中进行的关于软饮料的长期干预研究太少。
我们比较了 SSSD 与等热量牛奶和无热量软饮料对总脂肪量和异位脂肪沉积(肝脏和肌肉组织)变化的影响。
超重受试者(n = 47)被随机分配到 4 种不同的测试饮料(6 个月内每天 1 L):SSSD(普通可乐)、等热量半脱脂牛奶、阿斯巴甜甜味健怡可乐和水。使用(1)H 磁共振波谱测量肝内脂肪和肌内脂肪的含量。其他终点包括脂肪量、脂肪分布(双能 X 射线吸收法和磁共振成像)和代谢危险因素。
与其他 3 组相比,常规可乐组的肝脂肪(132-143%,性别调整平均值;P < 0.01)、骨骼肌脂肪(117-221%;P < 0.05)、内脏脂肪(24-31%;P < 0.05)、血甘油三酯(32%;P < 0.01)和总胆固醇(11%;P < 0.01)的相对变化在 6 个月干预结束时显著更高。4 种饮料组之间的总脂肪量没有显著差异。与常规可乐相比,牛奶和健怡可乐使收缩压降低了 10-15%(P < 0.05)。否则,健怡可乐的作用与水相似。
6 个月内每天摄入 SSSD 会增加异位脂肪堆积和脂质,与牛奶、健怡可乐和水相比。因此,每天摄入 SSSD 可能会增加心血管和代谢疾病的风险。本试验在 clinicaltrials.gov 上注册为 NCT00777647。